- United States
- /
- Chemicals
- /
- NYSE:SCL
Assessing Stepan’s Valuation After Q3 Earnings and Dividend Increase
Reviewed by Simply Wall St
Stepan (SCL) has announced its third-quarter earnings, reporting higher sales but a drop in net income compared to a year ago. At the same time, the company is raising its quarterly dividend by 2.6%.
See our latest analysis for Stepan.
After a tough stretch, Stepan’s latest earnings and dividend bump drew a bit of positive attention, but momentum has yet to turn. While the share price climbed 1.14% in the last day, the 1-year total shareholder return stands at a disappointing -40.26%. Short-term pops aside, a long-term turnaround would require convincing evidence that both profits and sentiment can shift gears meaningfully.
If you're watching for signs of recovery and want a fresh perspective, now could be an ideal time to discover fast growing stocks with high insider ownership
With shares still well below prior highs and trading at a substantial discount to estimated intrinsic value, the real question is whether this downturn creates a rare buying window or if markets are already bracing for muted growth ahead.
Most Popular Narrative: 45.9% Undervalued
Compared to the recent close of $44.47, the most followed narrative suggests Stepan’s fair value is dramatically higher. This sharp gap stands out even among the sector’s typically cyclical stories.
The startup of the new Pasadena, Texas site is expected to reach full contribution in the second half of 2025, which could boost volume growth and supply chain savings. This is likely to impact revenue and margins positively.
Want to see the model behind this outlook? The narrative’s valuation brings together ambitious assumptions on growth rates, margin expansion, and future multiples for Stepan. Ready to uncover the major drivers powering such a bold price target? See what’s fueling this calculated optimism.
Result: Fair Value of $82.21 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent high interest rates and ongoing macroeconomic uncertainties could undermine revenue growth and margin recovery if conditions do not improve.
Find out about the key risks to this Stepan narrative.
Build Your Own Stepan Narrative
If you want to dive into the numbers and shape your own view, it’s quick and simple to create a personal narrative that reflects your outlook. Do it your way
A great starting point for your Stepan research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Looking for More Investment Ideas?
If you want to stay ahead of the market, now’s the time to act, not wait. Strong opportunities await those who explore further.
- Capitalize on the latest breakthroughs in artificial intelligence by checking out these 25 AI penny stocks driving innovation and reshaping entire industries.
- Maximize your returns with these 855 undervalued stocks based on cash flows that our model flags as trading well below their true worth. Don’t let potential bargains slip by.
- Boost your passive income stream with these 15 dividend stocks with yields > 3% consistently rewarding shareholders with yields above 3%, helping you build wealth steadily.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:SCL
Stepan
Produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide.
Good value with adequate balance sheet and pays a dividend.
Similar Companies
Market Insights
Community Narratives

